Published in Int J Mol Sci on September 30, 2015
NIH Image to ImageJ: 25 years of image analysis. Nat Methods (2012) 84.41
Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A (1985) 68.48
WebLogo: a sequence logo generator. Genome Res (2004) 59.58
A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation. Protein Sci (1999) 6.05
DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution. Proc Natl Acad Sci U S A (1994) 5.69
Reproducibility: Standardize antibodies used in research. Nature (2015) 4.59
Mutagenic PCR. PCR Methods Appl (1994) 3.33
An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues. J Mol Biol (1996) 3.15
Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization. Cell (2013) 3.04
Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins. J Mol Biol (2003) 2.81
The fibronectin type III domain as a scaffold for novel binding proteins. J Mol Biol (1998) 2.65
Beyond natural antibodies: the power of in vitro display technologies. Nat Biotechnol (2011) 2.41
High-affinity single-domain binding proteins with a binary-code interface. Proc Natl Acad Sci U S A (2007) 2.18
Filamentous phage display in the new millennium. Chem Rev (2005) 2.17
Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition. Proc Natl Acad Sci U S A (2004) 2.17
Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis. Cell (2011) 2.11
Multivalent avimer proteins evolved by exon shuffling of a family of human receptor domains. Nat Biotechnol (2005) 1.99
Immobilized metal ion affinity chromatography. Protein Expr Purif (1992) 1.95
A designed ankyrin repeat protein evolved to picomolar affinity to Her2. J Mol Biol (2007) 1.71
Biotinylation of proteins in vivo and in vitro using small peptide tags. Methods Enzymol (2000) 1.67
scFv antibody: principles and clinical application. Clin Dev Immunol (2012) 1.64
Picomolar affinity fibronectin domains engineered utilizing loop length diversity, recursive mutagenesis, and loop shuffling. J Mol Biol (2008) 1.64
DARPins and other repeat protein scaffolds: advances in engineering and applications. Curr Opin Biotechnol (2011) 1.61
Nanobody-based products as research and diagnostic tools. Trends Biotechnol (2014) 1.50
A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain. Nat Struct Mol Biol (2010) 1.47
Correcting errors in synthetic DNA through consensus shuffling. Nucleic Acids Res (2005) 1.46
Optimizing the affinity and specificity of proteins with molecular display. Mol Biosyst (2005) 1.44
Antibody fragments: hope and hype. MAbs (2010) 1.42
Monobodies: antibody mimics based on the scaffold of the fibronectin type III domain. Methods Mol Biol (2007) 1.41
The intrinsic contributions of tyrosine, serine, glycine and arginine to the affinity and specificity of antibodies. J Mol Biol (2008) 1.41
A decade of yeast surface display technology: where are we now? Comb Chem High Throughput Screen (2008) 1.37
An affibody in complex with a target protein: structure and coupled folding. Proc Natl Acad Sci U S A (2003) 1.35
SUMO fusion technology for enhanced protein production in prokaryotic and eukaryotic expression systems. Methods Mol Biol (2009) 1.33
High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment. Cancer Res (1999) 1.32
Affibody molecules: new protein domains for molecular imaging and targeted tumor therapy. Curr Opin Drug Discov Devel (2007) 1.30
Phage display: selecting straws instead of a needle from a haystack. Molecules (2011) 1.30
Teaching an old scaffold new tricks: monobodies constructed using alternative surfaces of the FN3 scaffold. J Mol Biol (2011) 1.29
A new generation of protein display scaffolds for molecular recognition. Protein Sci (2006) 1.29
Lipocalins as a scaffold. Biochim Biophys Acta (2000) 1.28
Limits for antibody affinity maturation and repertoire diversification in hypervaccinated humans. J Immunol (2011) 1.27
Tailoring in vitro evolution for protein affinity or stability. Proc Natl Acad Sci U S A (2001) 1.26
FN3: a new protein scaffold reaches the clinic. Drug Discov Today (2009) 1.23
Alternative binding proteins: anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities. FEBS J (2008) 1.17
Biotechnological applications of recombinant single-domain antibody fragments. Microb Cell Fact (2011) 1.16
Yeast display of antibody fragments: a discovery and characterization platform. J Immunol Methods (2004) 1.12
Deep sequencing of phage display libraries to support antibody discovery. Methods (2013) 1.11
In vitro evolution of single-chain antibodies using mRNA display. Nucleic Acids Res (2006) 1.11
Antibody mimics based on human fibronectin type three domain engineered for thermostability and high-affinity binding to vascular endothelial growth factor receptor two. Protein Eng Des Sel (2005) 1.08
Molecular recognition properties of FN3 monobodies that bind the Src SH3 domain. Chem Biol (2004) 1.08
mRNA display selection of a high-affinity, modification-specific phospho-IkappaBalpha-binding fibronectin. ACS Chem Biol (2008) 1.07
Adnectins: engineered target-binding protein therapeutics. Protein Eng Des Sel (2010) 1.07
Synthetic antibodies: concepts, potential and practical considerations. Methods (2012) 1.06
Random mutagenesis by error-prone PCR. Methods Mol Biol (2010) 1.04
High-throughput biotinylation of proteins. Methods Mol Biol (2009) 0.99
DARPins recognizing the tumor-associated antigen EpCAM selected by phage and ribosome display and engineered for multivalency. J Mol Biol (2011) 0.97
Designed ankyrin repeat proteins (DARPins) as novel isoform-specific intracellular inhibitors of c-Jun N-terminal kinases. ACS Chem Biol (2012) 0.93
Computational analysis of off-rate selection experiments to optimize affinity maturation by directed evolution. Protein Eng Des Sel (2010) 0.93
Designing proteins that work using recombinant technologies. Curr Pharm Biotechnol (2002) 0.91
Affinity maturation by phage display. Methods Mol Biol (2009) 0.91
Protein selection using yeast surface display. Methods (2012) 0.90
Fibronectin type III domain based monobody with high avidity. Biochemistry (2007) 0.90
Advantages of mRNA display selections over other selection techniques for investigation of protein-protein interactions. Expert Rev Proteomics (2011) 0.88
Ribosome display: a perspective. Methods Mol Biol (2012) 0.86
Improvements to the Kunkel mutagenesis protocol for constructing primary and secondary phage-display libraries. Methods (2012) 0.84
Somatic mutagenesis in autoimmunity. Autoimmunity (2013) 0.84
Isolation of monobodies that bind specifically to the SH3 domain of the Fyn tyrosine protein kinase. N Biotechnol (2011) 0.83
Recombinant renewable polyclonal antibodies. MAbs (2015) 0.83
Primer extension mutagenesis powered by selective rolling circle amplification. PLoS One (2012) 0.81
AXM mutagenesis: an efficient means for the production of libraries for directed evolution of proteins. J Immunol Methods (2013) 0.81
Characterization of protein-protein interactions by isothermal titration calorimetry. Methods Mol Biol (2015) 0.78
In vivo elimination of parental clones in general and site-directed mutagenesis. J Immunol Methods (2014) 0.78
Use of micro-emulsion technology for the directed evolution of antibodies. Methods (2012) 0.77